Intellect Neurosciences, Inc.: 10-K filed 2015-10-14
What Intellect Neurosciences, Inc. reported in its annual report filed 2015-10-14 (fiscal FY 2015): 23 published measures, 45 facts as tagged in accession 0001615774-15-002920.
This filing
- Form
- 10-K (annual report)
- Filed
- 2015-10-14
- Fiscal period
- fiscal FY 2015
- Accession
- 0001615774-15-002920 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Intellect Neurosciences, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 26,108 | USD | |
| At 2014-06-30 | 2,250 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 21,116,097 | USD | |
| At 2014-06-30 | 28,163,041 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | -21,089,989 | USD | |
| At 2014-06-30 | -28,160,791 | USD | |
| At 2013-06-30 | -13,548,426 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 23,858 | USD | |
| At 2013-06-30 | 5,138 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 5,705,273 | USD | 365 |
| 2013-07-01 to 2014-06-30 | -15,051,544 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | -93,238,237 | USD | |
| At 2014-06-30 | -98,943,510 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 2,528,108 | shares | 365 |
| 2013-07-01 to 2014-06-30 | 1,279,007 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 64,398,335 | shares | 365 |
| 2013-07-01 to 2014-06-30 | 1,279,007 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 2.26 | USD/shares | 365 |
| 2013-07-01 to 2014-06-30 | -11.77 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 0.05 | USD/shares | 365 |
| 2013-07-01 to 2014-06-30 | -11.77 | USD/shares | 365 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 142,000 | USD | 365 |
| 2013-07-01 to 2014-06-30 | 307,250 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | -890,562 | USD | 365 |
| 2013-07-01 to 2014-06-30 | -1,137,240 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 23,858 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 5,231,163 | USD | 365 |
| 2013-07-01 to 2014-06-30 | 13,168,563 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 20,776,967 | USD | |
| At 2014-06-30 | 27,435,838 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 78,854 | USD | 365 |
| 2013-07-01 to 2014-06-30 | 82,620 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 3,550,336 | shares | |
| At 2014-06-30 | 1,728,915 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 72,144,582 | USD | |
| At 2014-06-30 | 70,780,870 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 2,957,500 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 1,072,000 | USD | |
| At 2014-06-30 | 2,883,700 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 5,705,273 | USD | 365 |
| 2013-07-01 to 2014-06-30 | -15,051,544 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 2,011,708 | USD | 365 |
| 2013-07-01 to 2014-06-30 | 1,054,620 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-06-30 | 6,595,835 | USD | 365 |
| 2013-07-01 to 2014-06-30 | -13,914,304 | USD | 365 |
Inspect the source
- Entity
- Intellect Neurosciences, Inc. / CIK 0001337905
- Captured
- SEC response SHA-256
236c93f4b109a1d0e3c5b32c838cb7ed4bcea14b1d8d77aad2aa400fa8dd42ce
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001337905.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))